English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Merck & Company, Inc.
Bree Gonzales
| Feb 2, 2022
Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Press release submission
| Sep 23, 2019
MERCK: New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care
Trending
Patient Daily
| Dec 23, 2024
Patient Advocacy Group: ‘Policymakers must remove barriers to the development and delivery of innovative’ health care
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
Discovery of replication hubs may lead to new antiviral therapies for norovirus
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
California student returns home after receiving life-saving heart transplant
+
Pharmaceuticals
Patient Daily
| Dec 17, 2024
Lung association warns against combined risks of smoking and radon
